about
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for ...
Read More
5.91
0.12
(2.07%)
55,163
XNAS Volume
XNAS 01 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Inventiva ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..